Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
Sudeep Pharma
|
Blue Jet Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | 2.06 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-0.59 % | 30.67 % | 36.48 % |
|
5yr average Equity Multiplier
|
3.58 | 1.75 | 1.66 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.92 | 0.8 |
|
5yr Avg Net Profit Margin
|
1.67 % | 20.26 % | 25.9 % |
|
Price to Book
|
2.32 | 10.48 | 6.1 |
|
P/E
|
23.05 | 54.7 | 21.74 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | 57.48 Days | 115.82 Days |
|
Inventory Days
|
60.56 Days | 44.61 Days | 61.76 Days |
|
Days Receivable
|
71.09 Days | 119.94 Days | 93.28 Days |
|
Days Payable
|
82.93 Days | 85.02 Days | 73.27 Days |
|
5yr Average Interest Coverage Ratio
|
6.25 | 33.52 | 1147.29 |
|
5yr Avg ROCE
|
6.7 % | 37.68 % | 45.94 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 27.79 % | 36.06 % |
|
5 yr average Debt to Equity
|
0.43 | 0.33 | 0.11 |
|
5yr CAGR Net Profit
|
22.48 % | 32.99 % | 16.07 % |
|
5yr Average Return on Assets
|
1.78 % | 18.08 % | 20.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 76.15 % | 79.81 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -23.85 % | -6.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
6.05 % | 5.67 % | -0.19 % |
|
Akums Drugs & Pharma
|
Sudeep Pharma
|
Blue Jet Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|